The dangers of mail-in genetic testing
By Daniel Munro,
Maclean's
| 06. 05. 2017
The risks from home-based genetic testing kits to privacy as well as people’s health appear far greater than the supposed benefits.
If you could have an early warning about your genetic risk of acquiring a serious disease or health condition, would you want it? For a few hundred dollars and a saliva sample, private companies will analyze parts of your genome and send you a report that quantifies your predisposition for conditions like Huntington’s disease and late-onset Alzheimer’s disease, and your carrier status for inherited conditions such as cystic fibrosis, Tay-Sach’s disease and sickle cell anemia. Armed with that information you could make lifestyle changes to lower risk, seek medical advice and treatment, and talk with friends and family about your plans for managing possible symptoms and outcomes.
But before we swab our cheeks and mail saliva samples to private labs, we should try to answer a few questions. Are we equipped to make sense of the test results? Could our misunderstanding produce more harm than good—for both individuals and society? How much should we worry about how DNA samples...
Related Articles
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Jonathan D. Grinstein, Genetic Engineering & Biotechnology News | 06.26.2024
Partial screenshot from The Bridge Recombination Mechanism
video by The Arc Institute on YouTube (CC)
Buried in a family of mobile genetic elements, Arc Institute researchers led by Patrick Hsu, PhD, have discovered an RNA-guided system that enables modular...
By Carl Zimmer, The New York Times | 05.31.2024
Last year, Jaume Pellicer led a team of fellow scientists into a forest on Grande Terre, an island east of Australia. They were in search of a fern called Tmesipteris oblanceolata. Standing just a few inches tall, it was not...
By Liz Szabo, The New York Times | 05.29.2024
By the time Rena Barrow-Wells gave birth to her fourth baby in 2020, she was well-versed in caring for a child with cystic fibrosis. She was also experienced in fighting for a diagnosis of the disease, which runs in families...